3PC-011 Hplc method development and validation to determinate resorcinol for quality control in pharmaceutical formulations

BACKGROUND: The hidradenitis suppurativa (HS) is an inflammatory skin disease. Resorcinol is a phenol derivate, and in topical self-treatment decreases the size and pain of HS lesions. Topical 15% resorcinol is prepared as a pharmaceutical compound. In current literature, high performance liquid chr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur J Hosp Pharm
Hauptverfasser: Ramos, J Cordero, Bohórquez, V Merino, Real, M Vazquez, Castro, C Muñoz, Cernická, D, Orland, A Fernandez, Fernandez, M Camean
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2018
Schlagworte:
Section 3: Production and compounding
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535285/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.63
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge